RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Isofol Medical AB (publ) Stock

Isofol Medical AB (publ) Debt 2024

Isofol Medical AB (publ) Debt

-138.15 SEK

Ticker

ISOFOL.ST

ISIN

SE0009581051

WKN

A2DPV6

In 2024, Isofol Medical AB (publ)'s total debt was -138.15 SEK, a -27.51% change from the -190.58 SEK total debt recorded in the previous year.

Isofol Medical AB (publ) Aktienanalyse

What does Isofol Medical AB (publ) do?

Isofol Medical AB (publ) is a Swedish company that was founded in 2006 and is listed on the Nasdaq Stockholm exchange. The company focuses on the development of medical solutions for a wide range of diseases, with a particular emphasis on cancer treatment. Isofol's main product is Modufolin, a proprietary technology that is an advancement of the well-known drug Folic Acid, commonly used in cancer therapy. Modufolin has a longer duration in the body, making it more effective in inhibiting tumor cell growth. Isofol also has a diagnostic division that specializes in developing tests for detecting Vitamin B12 levels in the body, which are crucial for identifying diseases such as dementia and anemia. Isofol Medical AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Isofol Medical AB (publ)'s Debt Structure

Isofol Medical AB (publ)'s total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Isofol Medical AB (publ)'s debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Isofol Medical AB (publ)’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Isofol Medical AB (publ)’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Isofol Medical AB (publ) stock

What is the debt of Isofol Medical AB (publ) this year?

Isofol Medical AB (publ) has a debt level of -138.15 SEK this year.

What was the debt of Isofol Medical AB (publ) compared to the previous year?

The debt of Isofol Medical AB (publ) has increased by -27.51% compared to the previous year dropped.

What are the consequences of high debt for investors in Isofol Medical AB (publ)?

High debt can pose a risk for investors of Isofol Medical AB (publ), as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Isofol Medical AB (publ)?

Low debt means that Isofol Medical AB (publ) has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Isofol Medical AB (publ) affect the company?

An increase in debt of Isofol Medical AB (publ) can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Isofol Medical AB (publ) affect the company?

A reduction in debt of Isofol Medical AB (publ) can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Isofol Medical AB (publ)?

Some factors that can influence the debt of Isofol Medical AB (publ) include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Isofol Medical AB (publ) so important for investors?

The debts of Isofol Medical AB (publ) are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Isofol Medical AB (publ) take to change the debt?

To change the debt, Isofol Medical AB (publ) can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Isofol Medical AB (publ) pay?

Over the past 12 months, Isofol Medical AB (publ) paid a dividend of 0.76 SEK . This corresponds to a dividend yield of about 33.57 %. For the coming 12 months, Isofol Medical AB (publ) is expected to pay a dividend of 0.76 SEK.

What is the dividend yield of Isofol Medical AB (publ)?

The current dividend yield of Isofol Medical AB (publ) is 33.57 %.

When does Isofol Medical AB (publ) pay dividends?

Isofol Medical AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Isofol Medical AB (publ)?

Isofol Medical AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Isofol Medical AB (publ)?

For the upcoming 12 months, dividends amounting to 0.76 SEK are expected. This corresponds to a dividend yield of 33.57 %.

In which sector is Isofol Medical AB (publ) located?

Isofol Medical AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Isofol Medical AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Isofol Medical AB (publ) from 2/20/2023 amounting to 0.755 SEK, you needed to have the stock in your portfolio before the ex-date on 2/14/2023.

When did Isofol Medical AB (publ) pay the last dividend?

The last dividend was paid out on 2/20/2023.

What was the dividend of Isofol Medical AB (publ) in the year 2023?

In the year 2023, Isofol Medical AB (publ) distributed 0 SEK as dividends.

In which currency does Isofol Medical AB (publ) pay out the dividend?

The dividends of Isofol Medical AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Isofol Medical AB (publ)

Our stock analysis for Isofol Medical AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Isofol Medical AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.